Holy Stone Healthcare Co., Ltd. (TPEX:4194)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.23
+0.04 (0.56%)
May 29, 2026, 1:45 PM CST
Market Cap1.06B -3.2%
Revenue (ttm)n/a
Net Income-111.35M
EPS-0.76
Shares Out 145.97M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume31,514
Open7.19
Previous Close7.19
Day's Range7.03 - 7.32
52-Week Range5.32 - 12.65
Beta0.71
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About Holy Stone Healthcare

Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing. It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcera... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4194
Full Company Profile

Financial Performance

Financial Statements